How Stem Cell Treatment Can Help Autism Patients
STEP 1
Uncomplicate The Condition
Autism is a complex developmental disorder, as a result of neurological trauma which affects normal brain function. The condition causes mild to severe impairment in the normal brain development of the child. The disorder is mainly characterized by weakened social interaction, impaired verbal or non-verbal communications and indulgence in repetitive behaviour.
STEP 2
Available Treatment Options
The traditional approach attempts to treat Autism by involving the use of antibiotics, anti‐inflammatory agents and hyperbaric oxygen. Although, till date, there is no complete cure available for autism that addresses the root cause of the condition, stem cell treatments are designed after assessing the clinical condition of the patient. Once eligible, the cells are administered in the patient’s body using our proprietary, non-invasive stem cell platform, ReoStem®.
STEP 3
IMPROVE THE QUALITY OF LIFE
Once the stem cells are administered in the body through veins, these cells can reach the targeted site and help reboot and revive the damaged nerve cells to restore their function back. Nutech MediWorld’s Stem Cell Treatment helps revive the damaged neurons. In addition, they have the potential to stimulate cells to boost up the repair leading to improvement in impaired functions. These stem cells have also observed to be promoting angiogenesis to increase oxygen supply to the blood for a speedy recovery from Autism.
- Improved Social Behaviour
- Improved Sensory Integration
- Enhanced Motor Skills
- Better Ability To Focus
- Reduced Hyperactivity
- Improved Communication
Nutech MediWorld's Approach to Autism Treatment
Nutech MediWorld's Proprietary Technology For Autism Treatment
Patent Protected Reostem® Technology
We use SCT-N® and SCT-NX® products, based on a proprietary stem cell platform, ReoStem®. ReoStem® is a unique, replicable, clinical-stage technology platform for the generation of allogenic stem cells.
Universal Applicability
Nutech MediWorld’s regenerative medicine products are universally applicable: they do not require tissue-matching or the co-administration of immunosuppressive drugs.
Highest Standards Of Safety
There is absolutely no evidence of teratoma generation or tumorigenesis associated with SCT-N® or SCT-NX® use in over 17 years of clinical practice across thousands of patients.
Cell Scalability & Expansion
Unique cell culture methodology allows scalability of cell expansion and production.